Omics Tools, MDx Stocks Rise with Biotech Surge in September | GenomeWeb

NEW YORK (GenomeWeb News) – Stocks for 'omics tools and molecular diagnostics firms climbed in September amid a general upswing for biotech stocks.

Among the 30 firms that comprise the GenomeWeb Daily News Index, only four saw a decline in their share price over the course of the month, and not a single stock was down in the double digits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.